[Value of CEA levels and of immunoscintigraphy (using CEA-marked antibodies) for the diagnosis and therapeutic monitoring of breast cancer: apropos of a case].
A 33-year-old woman, who at 29 underwent mastectomy for a localised breast cancer (TINOMO), presented a relapse shown by a rapid rise in seric level of CEA. The classical complete work-up was negative. The location of the relapse was demonstrated by anti-CEA immunoscintigraphy. Radiotherapy, hormonotherapy and chemotherapy allowed to achieve a complete remission with normalization of CEA level and of immunoscintigraphy.
Doalto
L
L
Service de Médecine Nucléaire, CHU Sart Tilman, Liège.
Paridaens
R
R
Dodion
P
P
Manil
L
L
Rigo
P
P
Fruhling
J
J
D000328:Adult; D000906:Antibodies; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000276:immunology; D002272:Carcinoembryonic Antigen / Q000276:immunology / Q000302:isolation & purification*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000175:diagnosis* / Q000276:immunology; D005260:Female; D006801:Humans; D015592:Immunoradiometric Assay; D007457:Iodine Radioisotopes; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*
D000906:Antibodies; D002272:Carcinoembryonic Antigen; D007457:Iodine Radioisotopes
Interêt du dosage du CEA et de l'immunoscintigraphie (par anticorps anti CEA marqués) pour le diagnostic et le monitoring thérapeutique du cancer du sein: à propos d'un cas.